1-15 of 77
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
MinuteCE®Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Steven Fishbane, MD
Nancy Helou, PhD
When Itching Hurts: Quality of Life Disruption in CKD-aP
MinuteCE®When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
Gabapentinoids: Safety Considerations and Downstream Outcomes
MinuteCE®Gabapentinoids: Safety Considerations and Downstream Outcomes
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
MinuteCE®From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
- advertisement
Spotlight on Assessment: Tools That Capture CKD-aP
MinuteCE®Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Reading Between the Lines: What PROMs Reveal About Itch
MinuteCE®Reading Between the Lines: What PROMs Reveal About Itch
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
What You Don’t See: A Patient’s View of Living with CKD-aP
MinuteCE®What You Don’t See: A Patient’s View of Living with CKD-aP
Steven Fishbane, MD
Nancy Helou, PhD
Winning the CKD-aP Battle: A United Physician-Nurse Front
MinuteCE®Winning the CKD-aP Battle: A United Physician-Nurse Front
Steven Fishbane, MD
Nancy Helou, PhD
Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
CME/CE Broadcast ReplayClear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
Linda Stein Gold, MD
Lakshi Aldredge, MSN, ANP-BC
Najat M. Watch, PA
The IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
CME/CEThe IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
Anthony Fernandez, MD, PhD
- advertisement
Case Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
CME/CECase Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
Carole Bitar, MD, FAAD
Matthew P. Giannetti, MD
Benjamin Ungar, MD
Calming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
CME/CECalming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
April W. Armstrong, MD, MPH
Melinda Gooderham, MSc, MD, FRCPC
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CELiving With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
